Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Long-Acting Lanreotide as a Volume Reducing Treatment of Polycystic Livers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00565097
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:34:56.286087+00:00
Published At
2009-02-17T00:00:00+00:00
Record Updated At
2009-02-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Polycystic Liver Disease", "Hepatomegaly", "Liver Diseases", "Polycystic Kidney, Autosomal Dominant"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2009-02-17"
protocolSection.identificationModule.nctId
"NCT00565097"
protocolSection.identificationModule.officialTitle
"Long-Acting Lanreotide as a Volume Reducing Treatment of Polycystic Livers"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Polycystic Liver Disease (protocolSection.conditionsModule.conditions)
  • Hepatomegaly (protocolSection.conditionsModule.conditions)
  • Liver Diseases (protocolSection.conditionsModule.conditions)
  • Polycystic Kidney, Autosomal Dominant (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.